Gland Pharma slips 10%, hits 52-week low on disappointing Q1 results

Q1 profit after tax tumbled 35 per cent YoY and 20 per cent QoQ to Rs 229 crore, due to lower operational income

Premium

Mumbai

4 min read Last Updated : Jul 21 2022 | 10:04 AM IST

Shares of Gland Pharma hit a 52-week low of Rs 2,232 as they slipped 10 per cent on the BSE in Thursday's intra-day trade. The company reported 35 per cent

Topics : Buzzing stocks Gland Pharma Markets

First Published: Jul 21 2022 | 9:53 AM IST

Explore News

Stock Market Live Updates Rajya Sabha Passes Women's Reservation Bill Stock To Watch Today Latest News Live Indi vs Aus ODI Playing 11 Apple's iPhone 15 Sale Parliament special session LIVE Gold-Silver Price Expendables 4 Glenmark Pharma Share

Companies News

Apple outpaces Samsung to become largest smartphone exporter from India Apple's iPhone 15 goes on sale today, long queues outside Mumbai store

Election News

Telangana IT Minister K T Rama Rao accuses PM Modi of misleading youth Court rejects Ashok Gehlot's acquittal plea in defamation case by Shekhawat

India News

Parliament special session: Rajya Sabha passes women's reservation Bill Parliament special session LIVE: LS logged 132% productivity, says Om Birla

Economy News

Discussion underway to ease FDI norms in space sector, says official India unlikely to export sugar in 2023-2024, says ED&F Man Commodities

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Continue

Gland Pharma slips 10%, hits 52-week low on disappointing Q1 results

Q1 profit after tax tumbled 35 per cent YoY and 20 per cent QoQ to Rs 229 crore, due to lower operational income

Also Read

Gland Pharma advances 9% on heavy volumes; stock hits 9-week high

Gland Pharma rides high on valuation comfort, strong growth prospects

Election results 2022: Date, time, how & where to watch counting of votes

Will India Inc see robust Q4 despite input cost pressure?

India Inc likely to see robust Q4 nos despite input cost pressure: Analysts

MARKET LIVE: Sensex, Nifty flat; Wipro sheds 2%, Realty, Metals firm

Stocks to Watch Today: Wipro, IndusInd Bank, Adani Enter, CEAT, Sonata, SBI

Stocks and sectors to bet on as the US economy faces a recession

Insurance stocks: Analysts see decent upside in HDFC Life, ICICI Lombard

Markets surge amid 'peak inflation' optimism, gain now 4% in 4 days

Explore News